Vital Farms (VITL) declined 1.37% to $9.34, underperforming the S&P 500's 0.02% loss. The stock has fallen 5.58% over the past month while the broader market gained 2.05%. Upcoming earnings are expected to show an EPS of -$0.13 (down 136.11% year-over-year) and revenue of $190.5 million (down 4.24%), with annual projections showing -$0.48 EPS and $777.9 million revenue. VITL holds a Zacks Rank of #3 (Hold) with no recent estimate changes.

Vital Farms (VITL) closed at $9.47, up 1.5% on the day but down 4.21% over the past month. The company faces challenging earnings expectations with projected EPS of -$0.13 (down 136% YoY) and quarterly revenue of $190.5 million (down 4.24% YoY). The stock holds a Zacks Rank #3 (Hold) rating, while its industry ranks in the bottom 18% of all sectors.

Vital Farms (VITL) has been trending on Zacks.com with shares down 6.6% over the past month. The company is expected to report a loss of $0.13 per share for the current quarter and -$0.48 for the fiscal year, though earnings are projected to recover to $0.28 per share next fiscal year. Revenue growth is modest at 2.4% for the current year and 5.7% for the next year. The stock has been assigned a Zacks Rank #3 (Hold) rating, suggesting it may perform in line with the broader market in the near term.

Vital Farms (VITL) closed at $9.42, up 1.84% for the day but down 6.75% over the past month. The company is expected to report negative EPS of -$0.13 and revenue of $190.5 million (down 4.24% YoY). For the full year, earnings are projected at -$0.48 per share with revenue of $777.9 million. The stock holds a Zacks Rank #3 (Hold) rating, while its industry ranks in the bottom 15% of all sectors.

Vital Farms (VITL) closed at $9.29, down 1.06%, underperforming the S&P 500. The company is expected to report negative EPS of -$0.13 and revenue of $190.5 million, down 4.24% year-over-year. Full-year estimates project -$0.48 EPS and $777.9 million revenue. The stock holds a Zacks Rank #3 (Hold) rating, with the Food - Miscellaneous industry ranked in the bottom 18% of all industries.

Pomerantz Law Firm has filed class action lawsuits against ImmunityBio, Inc., New Era Energy & Digital, Inc., and Vital Farms, Inc. for alleged securities fraud and unlawful business practices. The primary case involves ImmunityBio, which faced an FDA warning letter on March 24, 2026, for continuing to promote its bladder-cancer drug Anktiva in a misleading manner despite previous warnings. The disclosure triggered a 21.12% stock price decline. Investors have until May 26, 2026, to request Lead Plaintiff status.

Pomerantz LLP has filed a class action lawsuit against Vital Farms, Inc., alleging securities fraud and unlawful business practices. The lawsuit was triggered after Vital Farms missed its 2025 revenue guidance ($759.44M vs. $775M guidance) and reported lower-than-expected earnings per share ($0.35 vs. $0.39 consensus). The company attributed underperformance to disruptions from an ERP system implementation. Vital Farms' stock fell 10.81% on the announcement. The deadline to join the class action as Lead Plaintiff is May 26, 2026.

The Schall Law Firm is seeking investors who purchased Vital Farms securities between May 8, 2025 and February 26, 2026 to join a class action lawsuit alleging securities fraud. The company allegedly made false and misleading statements about risks related to its new ERP system implementation, downplaying actual delays that caused the company to miss earnings targets.

Rosen Law Firm reminds investors in Vital Farms, Inc. (NASDAQ: VITL) who purchased securities between May 8, 2025 and February 26, 2026 of the May 26, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that Vital Farms made false or misleading statements regarding risks associated with its ERP system implementation, understated the impact of resulting delays, and missed 2025 profit guidance and earnings per share consensus targets.

Rosen Law Firm reminds investors in Vital Farms, Inc. (NASDAQ: VITL) who purchased securities between May 8, 2025 and February 26, 2026 of the May 26, 2026 lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Vital Farms made false and misleading statements regarding risks and impacts of delays in its enterprise resource planning (ERP) system rollout, which caused the company to miss its full year 2025 earnings guidance.

Rosen Law Firm is reminding investors in Super Micro Computer, Inc. (SMCI) and Vital Farms, Inc. (VITL) of the May 26, 2026 deadline to join securities class action lawsuits. SMCI investors claim the company made false statements about server sales to China-based companies that violated U.S. export control laws. Both lawsuits target investors who suffered losses exceeding $100,000 during their respective dispute periods.

Rosen Law Firm reminds investors in Vital Farms, Inc. (VITL) of the May 26, 2026 deadline to join a securities class action lawsuit. The lawsuit alleges that company defendants made false statements regarding risks associated with their ERP system implementation, which caused delays and resulted in missing 2025 profit guidance and earnings per share consensus estimates, causing investor losses.